AU Patent

AU2008257505B2 — Stable non-aqueous pharmaceutical compositions

Assigned to Novo Nordisk AS · Expires 2013-05-16 · 13y expired

What this patent protects

The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising dehydrated active polypeptide comprising 10 - 100 amino acids and at least one semi-polar protic organic so…

USPTO Abstract

The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising dehydrated active polypeptide comprising 10 - 100 amino acids and at least one semi-polar protic organic solvent.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008257505B2
Jurisdiction
AU
Classification
—
Expires
2013-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.